RMAM
IHE icon

Raab & Moskowitz Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Raab & Moskowitz Asset Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$374K Hold
3,779
– – 0.08% 159
2026
Q1 		$328K Sell
3,779
-293
-7% -$25.6K 0.07% 161
2025
Q4 		$345K Hold
4,072
– – 0.08% 160
2025
Q3 		$295K Sell
4,072
-621
-13% -$42.8K 0.07% 168
2025
Q2 		$308K Sell
4,693
-110
-2% -$7.16K 0.07% 164
2025
Q1 		$339K Buy
4,803
+204
+4% +$14.2K 0.09% 151
2024
Q4 		$302K Hold
4,599
– – 0.07% 152
2024
Q3 		$325K Hold
4,599
– – 0.08% 149
2024
Q2 		$305K Hold
4,599
– – 0.08% 145
2024
Q1 		$312K Sell
4,599
-636
-12% -$42K 0.09% 146
2023
Q4 		$324K Buy
5,235
+624
+14% +$36.7K 0.1% 135
2023
Q3 		$272K Hold
4,611
– – 0.1% 143
2023
Q2 		$275K Hold
4,611
– – 0.09% 141
2023
Q1 		$269K Hold
4,611
– – 0.1% 139
2022
Q4 		$286K Hold
4,611
– – 0.11% 135
2022
Q3 		$260K Sell
4,611
-21
-0.5% -$1.29K 0.11% 138
2022
Q2 		$295K Sell
4,632
-84
-2% -$5.33K 0.12% 134
2022
Q1 		$305K Sell
4,716
-657
-12% -$41.6K 0.1% 138
2021
Q4 		$358K Sell
5,373
-18
-0.3% -$1.14K 0.12% 131
2021
Q3 		$329K Hold
5,391
– – 0.12% 129
2021
Q2 		$334K Sell
5,391
-1,017
-16% -$61.8K 0.12% 128
2021
Q1 		$379K Sell
6,408
-174
-3% -$10.5K 0.15% 111
2020
Q4 		$393K Sell
6,582
-117
-2% -$6.67K 0.16% 110
2020
Q3 		$365K Sell
6,699
-1,353
-17% -$73K 0.17% 106
2020
Q2 		$413K Sell
8,052
-1,335
-14% -$67.1K 0.2% 101
2020
Q1 		$421K Sell
9,387
-186
-2% -$9.38K 0.23% 93
2019
Q4 		$510K Sell
9,573
-45
-0.5% -$2.22K 0.2% 104
2019
Q3 		$448K Hold
9,618
– – 0.2% 112
2019
Q2 		$483K Sell
9,618
-297
-3% -$14.7K 0.21% 106
2019
Q1 		$508K Sell
9,915
-195
-2% -$9.7K 0.23% 101
2018
Q4 		$474K Sell
10,110
-105
-1% -$5.38K 0.23% 99
2018
Q3 		$571K Sell
10,215
-225
-2% -$12.3K 0.24% 98
2018
Q2 		$526K Sell
10,440
-231
-2% -$11.5K 0.25% 103
2018
Q1 		$524K Buy
10,671
+51
+0.5% +$2.62K 0.26% 101
2017
Q4 		$546K Buy
10,620
+636
+6% +$32.7K 0.26% 94
2017
Q3 		$501K Hold
9,984
– – 0.24% 101
2017
Q2 		$491K Buy
9,984
+5,148
+106% +$260K 0.24% 101
2017
Q1 		$243K Sell
4,836
-1,878
-28% -$93K 0.13% 125
2016
Q4 		$316K Buy
6,714
+192
+3% +$9.11K 0.17% 120
2016
Q3 		$324K Buy
+6,522
New +$331K 0.18% 117
2015
Q1 		– Sell
-1,380
Closed -$70K – 239
2014
Q4 		$70K Buy
+1,380
New +$67.2K 0.04% 169

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Raab & Moskowitz Asset Management's IHE Position: Q2 2026 in Review

Raab & Moskowitz Asset Management held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 3,779 shares worth $374K. The position accounts for 0.08% of the portfolio, ranked #159.

Raab & Moskowitz Asset Management first reported a position in IHE in Q4 2014 and has held it in 41 quarters since. The position peaked at $571K in Q3 2018. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Raab & Moskowitz Asset Management held 3,779 shares of iShares US Pharmaceuticals ETF worth $374K as of Q2 2026.
  • Raab & Moskowitz Asset Management left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
  • iShares US Pharmaceuticals ETF made up 0.08% of Raab & Moskowitz Asset Management's portfolio in Q2 2026, its #159 holding.
  • Raab & Moskowitz Asset Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2014 and has held it in 41 quarters since.
  • Raab & Moskowitz Asset Management's iShares US Pharmaceuticals ETF position peaked at $571K in Q3 2018.
  • 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Raab & Moskowitz Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.